Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

1.1K
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Networking is Essential for the Proper Management of Rare Cancers: From Recognition to Implementation.

Annals of surgical oncology·2026
Same author

Chemoradiotherapy for anal canal cancers: Does the choice of boost technique matter?

Journal of contemporary brachytherapy·2026
Same author

Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas.

Translational oncology·2026
Same author

Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancer.

Cell death & disease·2026
Same author

Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts.

Oncoimmunology·2026
Same author

Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: May 2, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K

[Peritoneal malignant mesothelioma: review and recent data].

Éliane Mery1, Juliette Hommell-Fontaine2, Mathieu Capovilla3

  • 1Département d'anatomie pathologique, institut Claudius-Regaud, 20, 24, rue du Pont-Saint-Pierre, 31052 Toulouse, France.

Annales De Pathologie
|March 18, 2014
PubMed
Summary
This summary is machine-generated.

Peritoneal malignant mesothelioma is a rare cancer. Accurate diagnosis using immunohistochemistry is crucial for effective treatment combining surgery and hyperthermic chemotherapy, improving patient outcomes.

Keywords:
ImmunohistochemistryImmunohistochimieMésothéliome malin péritonéalPeritoneal malignant mesotheliomaPrognosisPronostic

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

8.8K

Related Experiment Videos

Last Updated: May 2, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

8.8K

Area of Science:

  • Oncology
  • Pathology

Background:

  • Peritoneal malignant mesothelioma is a rare neoplasm originating from peritoneal mesothelial cells.
  • It predominantly affects males aged 47-60.5 years, with potential links to asbestos exposure, SV40 virus, and chronic peritonitis.
  • Clinical presentation and imaging are often non-specific, complicating early diagnosis.

Purpose of the Study:

  • To provide an overview of peritoneal malignant mesothelioma.
  • To discuss its classification, diagnostic challenges, and therapeutic strategies.

Main Methods:

  • Review of the 2004 World Health Organization (WHO) classification of peritoneal mesothelioma.
  • Emphasis on the indispensable role of immunohistochemistry for diagnosis.
  • Discussion of treatment modalities.

Main Results:

  • The 2004 WHO classification identifies three main types: diffuse epithelioid, sarcomatoid, and biphasic mesothelioma, each with variants.
  • Immunohistochemistry is essential for accurate diagnosis, utilizing specific antibody panels.
  • Combined radical surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) is a promising therapeutic approach.

Conclusions:

  • Accurate diagnosis of peritoneal malignant mesothelioma is critical for treatment planning.
  • The combination of surgery and HIPEC offers improved prognosis for this aggressive malignancy.